Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer
Phase 3 Completed
315 enrolled 11 charts
Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer
Phase 2 Completed
39 enrolled 21 charts
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
Phase 3 Completed
159 enrolled 9 charts
Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Phase 2 Completed
211 enrolled 17 charts
TARGET
Phase 2 Completed
19 enrolled 12 charts
Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer
Phase 2 Completed
37 enrolled 5 charts
A Phase II Study of PROSTVAC-V (Vaccinia)/TRICOM and PROSTVAC-F (Fowlpox)/TRICOM With GM-CSF in Patients With PSA Progression After Local Therapy for Prostate Cancer
Phase 2 Completed
50 enrolled 7 charts
Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Phase 3 Completed
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
Phase 3 Completed
1,000 enrolled
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Phase 3 Completed
400 enrolled
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
Phase 3 Completed
6,000 enrolled
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
Phase NA Completed
150 enrolled
Combination Chemotherapy in Treating Women With Breast Cancer
Phase 3 Completed
446 enrolled
Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate Cancer
Phase 3 Completed